BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23742144)

  • 1. A multiparametric clinical and echocardiographic score to risk stratify patients with chronic systolic heart failure: derivation and testing.
    Fontanive P; Miccoli M; Simioniuc A; Angelillis M; Di Bello V; Baggiani A; Bongiorni MG; Marzilli M; Dini FL
    Echocardiography; 2013 Nov; 30(10):1172-9. PubMed ID: 23742144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining blood flow and tissue Doppler imaging with N-terminal pro-type B natriuretic peptide for risk stratification of clinically stable patients with systolic heart failure.
    Dini FL; Rosa GM; Fontanive P; Santonato V; Napoli AM; Ciuti M; Di Bello V
    Eur J Echocardiogr; 2010 May; 11(4):333-40. PubMed ID: 20051423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of furosemide dose with clinical status, left ventricular dysfunction, natriuretic peptides, and outcome in clinically stable patients with chronic systolic heart failure.
    Dini FL; Guglin M; Simioniuc A; Donati F; Fontanive P; Pieroni A; Orsini E; Caravelli P; Marzilli M
    Congest Heart Fail; 2012; 18(2):98-106. PubMed ID: 22432556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal protype-B natriuretic peptide and Doppler diastolic variables are incremental for risk stratification of patients with NYHA class I-II systolic heart failure.
    Dini FL; Fontanive P; Buralli S; Panicucci E; Andreini D; Conti U; De Tommasi SM
    Int J Cardiol; 2009 Aug; 136(2):144-50. PubMed ID: 18649955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
    Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
    Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right atrial volume index in chronic systolic heart failure and prognosis.
    Sallach JA; Tang WH; Borowski AG; Tong W; Porter T; Martin MG; Jasper SE; Shrestha K; Troughton RW; Klein AL
    JACC Cardiovasc Imaging; 2009 May; 2(5):527-34. PubMed ID: 19442936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung ultrasound for the evaluation of pulmonary congestion in outpatients: a comparison with clinical assessment, natriuretic peptides, and echocardiography.
    Miglioranza MH; Gargani L; Sant'Anna RT; Rover MM; Martins VM; Mantovani A; Weber C; Moraes MA; Feldman CJ; Kalil RA; Sicari R; Picano E; Leiria TL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1141-51. PubMed ID: 24094830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incremental prognostic value of assessing left ventricular myocardial mechanics in patients with chronic systolic heart failure.
    Motoki H; Borowski AG; Shrestha K; Troughton RW; Tang WH; Thomas JD; Klein AL
    J Am Coll Cardiol; 2012 Nov; 60(20):2074-81. PubMed ID: 23083779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
    Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
    Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiographic predictors of adverse short-term outcomes after heart surgery in patients with mitral regurgitation and pulmonary hypertension.
    Corciova FC; Corciova C; Georgescu CA; Enache M; Anghel D; Bartos O; Tinica G
    Heart Surg Forum; 2012 Jun; 15(3):E127-32. PubMed ID: 22698598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 'Echo Heart Failure Score': an echocardiographic risk prediction score of mortality in systolic heart failure.
    Carluccio E; Dini FL; Biagioli P; Lauciello R; Simioniuc A; Zuchi C; Alunni G; Reboldi G; Marzilli M; Ambrosio G
    Eur J Heart Fail; 2013 Aug; 15(8):868-76. PubMed ID: 23512095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy.
    Dini FL; Conti U; Fontanive P; Andreini D; Panicucci E; De Tommasi SM
    Am J Cardiol; 2008 Aug; 102(4):463-8. PubMed ID: 18678307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
    J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of, associations with, and prognostic value of tricuspid annular plane systolic excursion (TAPSE) among out-patients referred for the evaluation of heart failure.
    Damy T; Kallvikbacka-Bennett A; Goode K; Khaleva O; Lewinter C; Hobkirk J; Nikitin NP; Dubois-Randé JL; Hittinger L; Clark AL; Cleland JG
    J Card Fail; 2012 Mar; 18(3):216-25. PubMed ID: 22385942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro B-type natriuretic peptide levels: correlation with echocardiographically determined left ventricular diastolic function in an ambulatory cohort.
    Dong SJ; de las Fuentes L; Brown AL; Waggoner AD; Ewald GA; Dávila-Román VG
    J Am Soc Echocardiogr; 2006 Aug; 19(8):1017-25. PubMed ID: 16880097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of renal impairment on myocardial function in outpatients with systolic heart failure: an echocardiographic and cardiac biomarker study.
    Bosselmann H; Tonder N; Sölétormos G; Rossing K; Iversen K; Goetze JP; Gustafsson F; Schou M
    Int J Cardiol; 2014 Dec; 177(3):942-8. PubMed ID: 25449505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right ventricular dysfunction is a major predictor of outcome in patients with moderate to severe mitral regurgitation and left ventricular dysfunction.
    Dini FL; Conti U; Fontanive P; Andreini D; Banti S; Braccini L; De Tommasi SM
    Am Heart J; 2007 Jul; 154(1):172-9. PubMed ID: 17584573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.